Prasad Raju Insider Trades

Insider Trading History

Track insider trading activity for Prasad Raju. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $984k 19,500 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 19,500 shares
$56.18
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $785k 15,565 shares
Last Trade
Mar 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$173k 3,708 shares
$46.78
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $973k 19,273 shares
Last Trade
Mar 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$289k 6,250 shares
$46.24
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $631k 12,500 shares
Last Trade
Mar 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$289k 6,250 shares
$46.24
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $1.94M 38,499 shares
Last Trade
Mar 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.05M 65,999 shares
$46.24
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $657k 13,023 shares
Last Trade
Mar 16, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$36.3k 750 shares
$48.42
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $898k 17,794 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$476k 9,869 shares
$48.26
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $1.19M 23,642 shares
Last Trade
Mar 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$823k 16,875 shares
$48.75
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $1.04M 20,625 shares
Last Trade
Mar 14, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$823k 16,875 shares
$48.75
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $2.11M 41,739 shares
Last Trade
Jan 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.13M 34,972 shares
$60.81
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $2.1M 41,667 shares
Last Trade
Jan 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.13M 34,972 shares
$60.81
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $341k 6,767 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.1M 34,972 shares
$60.19
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $1.84M 36,467 shares
Last Trade
Jan 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.73M 29,700 shares
$58.19
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $3.87M 76,639 shares
Last Trade
Jan 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.73M 29,700 shares
$58.19
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $885k 17,534 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.79M 29,700 shares
$60.15
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $668k 13,239 shares
Last Trade
Dec 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$560k 10,000 shares
$55.95
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $833k 16,500 shares
Last Trade
Oct 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 16,500 shares
$67.74
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $1.01M 20,000 shares
Last Trade
May 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$726k 20,000 shares
$36.29
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $846k 16,767 shares
Last Trade
Mar 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$90.6k 2,197 shares
$41.23
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $946k 18,750 shares
Last Trade
Mar 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$257k 6,250 shares
$41.17
$50.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up